|
- 2019
Combined targeted therapy and immunotherapy in melanoma: a review of the impact on the tumor microenvironment and outcomes of early clinical trialsKeywords: BRAF inhibitor, immunotherapy, MEK inhibitor, melanoma, targeted therapy, tumor microenvironment Abstract:
|